TC BioPharm (Holdings) plc American Depositary Shares
TCBP
TCBP was delisted on the 21st of March, 2025.
7 hedge funds and large institutions have $48.9K invested in TC BioPharm (Holdings) plc American Depositary Shares in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
17% more funds holding
Funds holding: 6 → 7 (+1)
36% less capital invested
Capital invested by funds: $77K → $48.9K (-$28.1K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
+$52.2K |
| 2 |
HI
Harbour Investments
Madison,
Wisconsin
|
+$1.53K |
| 3 |
NECFA
New England Capital Financial Advisors
Meriden,
Connecticut
|
+$1.32K |
| 4 |
Morgan Stanley
New York
|
+$611 |
| 5 |
SWM
Sanctuary Wealth Management
Pocatello,
Idaho
|
+$102 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PTP
Platform Technology Partners
New York
|
-$41.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$18.5K |
| 3 |
CAG
Csenge Advisory Group
Clearwater,
Florida
|
-$9.89K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.73K |
| 5 |
S
SignatureFD
Atlanta,
Georgia
|
-$611 |
TCBP Hedge Fund Activity: Q3 2024 in Review
7 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q3 2024, worth a combined $48.9K — down 36% from $77K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new TCBP positions and 4 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was FNY Investment Advisers, opening a new position worth an estimated $52.2K. The largest seller was Platform Technology Partners, exiting entirely with an estimated $41.2K sold.
- 7 institutional investors held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q3 2024, up from 6 in Q2 2024.
- Funds reported $48.9K of TC BioPharm (Holdings) plc American Depositary Shares stock for Q3 2024, down 36% quarter-over-quarter.
- 5 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q3 2024 and 4 closed out, a net change of +1 holder.
- The largest TC BioPharm (Holdings) plc American Depositary Shares buyer in Q3 2024 was FNY Investment Advisers, an estimated $52.2K added.
- The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q3 2024 was Platform Technology Partners, an estimated $41.2K sold.
Based on aggregated 13F filings for Q3 2024.